We are live on ! Find out more

3,235 hedge funds and large institutions have $216B invested in Merck in 2022 Q4 according to their latest regulatory filings, with 393 funds opening new positions, 1,189 increasing their positions, 1,326 reducing their positions, and 94 closing their positions.

New
Increased
Maintained
Reduced
Closed

318% more first-time investments, than exits

New positions opened: 393 | Existing positions closed: 94

53% more funds holding in top 10

Funds holding in top 10: 224342 (+118)

32% more capital invested

Capital invested by funds: $163B → $216B (+$52.9B)

8% more funds holding

Funds holding: 2,9903,235 (+245)

4% more call options, than puts

Call options by funds: $2.63B | Put options by funds: $2.53B

0.45% more ownership

Funds ownership: 75.08%75.53% (+0.45%)

10% less repeat investments, than reductions

Existing positions increased: 1,189 | Existing positions reduced: 1,326

Holders
3,235
Holders Change
+245
Holders Change %
+8.19%
% of All Funds
51.99%
Holding in Top 10
342
Holding in Top 10 Change
+118
Holding in Top 10 Change %
+52.68%
% of All Funds
5.5%
New
393
Increased
1,189
Reduced
1,326
Closed
94
Calls
$2.63B
Puts
$2.53B
Net Calls
+$98.2M
Net Calls Change
-$528M
Name Holding Trade Value Shares
Change
Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$25.2B +$314M +3,071,530 +1%
BlackRock
2
BlackRock
New York
$23.8B +$22.9M +223,625 +0.1%
State Street
3
State Street
Massachusetts
$13.2B +$66.5M +650,528 +0.6%
Wellington Management Group
4
Wellington Management Group
Massachusetts
$6.88B +$2.23B +21,859,699 +54%
Geode Capital Management
5
Geode Capital Management
Massachusetts
$5.35B +$24.4M +238,356 +0.5%
AWA
6
Arete Wealth Advisors
Illinois
$4.88B +$176K +1,724 +4%
Morgan Stanley
7
Morgan Stanley
New York
$4.64B +$409M +4,000,816 +11%
Bank of America
8
Bank of America
North Carolina
$4.46B +$19.7M +192,688 +0.5%
Bank of New York Mellon
9
Bank of New York Mellon
New York
$3.37B -$66.8M -653,582 -2%
Northern Trust
10
Northern Trust
Illinois
$3.35B +$33.1M +323,762 +1%
Charles Schwab
11
Charles Schwab
California
$3.33B -$99.4M -972,799 -3%
Fidelity Investments
12
Fidelity Investments
Massachusetts
$3.05B +$435M +4,255,943 +18%
T. Rowe Price Associates
13
T. Rowe Price Associates
Maryland
$2.92B +$1.13B +11,051,945 +72%
Norges Bank
14
Norges Bank
Norway
$2.74B +$78.2M +765,411 +3%
Massachusetts Financial Services
15
Massachusetts Financial Services
Massachusetts
$2.65B -$323M -3,158,675 -12%
JP Morgan Chase
16
JP Morgan Chase
New York
$2.64B +$31.2M +305,417 +1%
Deutsche Bank
17
Deutsche Bank
Germany
$2.31B -$62.8M -614,680 -3%
Legal & General Group
18
Legal & General Group
United Kingdom
$2.13B -$52.6M -514,995 -3%
Ameriprise
19
Ameriprise
Minnesota
$2.1B -$22.4M -218,769 -1%
Wells Fargo
20
Wells Fargo
California
$2.03B -$58.5M -572,173 -3%
Invesco
21
Invesco
Georgia
$1.99B +$27.7M +270,778 +2%
N
22
Nuveen
North Carolina
$1.81B +$333M +3,262,048 +25%
Royal Bank of Canada
23
Royal Bank of Canada
Ontario, Canada
$1.73B -$158M -1,542,822 -9%
State Farm Mutual Automobile Insurance
24
State Farm Mutual Automobile Insurance
Illinois
$1.58B
Janus Henderson Group
25
Janus Henderson Group
United Kingdom
$1.49B -$1.43B -14,000,356 -51%

MRK Hedge Fund Activity: Q4 2022 in Review

3,235 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q4 2022, worth a combined $216B — up 32% from $163B a quarter earlier.

Buyers outnumbered sellers: 393 funds opened new MRK positions and 94 closed out — a net gain of 299 holders — while 1,189 added to existing stakes and 1,326 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $2.23B. The largest seller was Janus Henderson Group, cutting an estimated $1.43B.

  • 3,235 institutional investors held Merck (MRK) as of Q4 2022, up from 2,990 in Q3 2022.
  • Funds reported $216B of Merck stock for Q4 2022, up 32% quarter-over-quarter.
  • 393 funds opened new Merck positions in Q4 2022 and 94 closed out, a net change of +299 holders.
  • The largest Merck buyer in Q4 2022 was Wellington Management Group, an estimated $2.23B added.
  • The largest Merck seller in Q4 2022 was Janus Henderson Group, an estimated $1.43B sold.

Based on aggregated 13F filings for Q4 2022.